Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: European Region
  • Asset Class: Equity
  • Geographic Focus: European Region

T Rowe Price Funds SICAV - European Structured Research Equity Fund

+ Add to Watchlist

TRPESRI:LX

19.93 EUR 0.09 0.45%

As of 00:59:30 ET on 02/27/2015.

Snapshot for T Rowe Price Funds SICAV - European Structured Research Equity Fund (TRPESRI)

Year To Date: +14.54% 3-Month: +12.98% 3-Year: +15.06% 52-Week Range: 15.75 - 19.93
1-Month: +6.75% 1-Year: +18.70% 5-Year: +12.36% Beta vs MXEU: 0.96

Mutual Fund Chart for TRPESRI

No chart data available.
  • TRPESRI:LX 19.93
  • 1M
  • 1Y
Interactive TRPESRI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TRPESRI

T Rowe Price Funds SICAV- European Structured Research Equity Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to provide long-term capital appreciation through investment in primarily transferable securities and Equity related securities.

Inception Date: 01-07-2005 Telephone: 352-27-47-251 Tel
Managers: ANN HOLCOMB / KAMRAN BAIG
Web Site: www.troweprice.com/institutional

Fundamentals for TRPESRI

NAV (on 2015-02-27) 19.93
Assets (M) (on 2015-02-27) 7.47
Fund Leveraged N
Minimum Investment 2,500,000.00
Minimum Subsequent Investment 100,000.00

Dividends for TRPESRI

No dividends reported

Fees & Expenses for TRPESRI

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.65

Top Fund Holdings for TRPESRI

Filing Date: 09/30/2014
Name Position Value % of Total
Novartis AG 2,973 221,745 3.393%
Nestle SA 3,202 185,724 2.842%
Royal Dutch Shell PLC 6,104 184,869 2.829%
Roche Holding AG 596 139,266 2.131%
Bayer AG 1,232 136,013 2.081%
GlaxoSmithKline PLC 7,156 130,269 1.993%
HSBC Holdings PLC 14,268 114,574 1.753%
Vodafone Group PLC 36,674 96,664 1.479%
Barclays PLC 30,805 89,990 1.377%
Eni SpA 4,753 88,786 1.359%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil